-
Immunol Rev. 2023
M. Heeg, and A. W. Goldrath.
2023/insights-into-phenotypic-and-functional-cd8-trm-heterogeneity -
J Exp Med. 2023
M. Heeg, and A. W. Goldrath.
2023/license-to-kill_-retinoic-acid-programs-t-cells-for-tissue-residency -
Nat Immunol. 2022
J. T. Crowl, M. Heeg, A. Ferry, J. J. Milner, K. D. Omilusik, C. Toma, Z. He, J. T. Chang, and A. W. Goldrath.
2022/tissue-resident-memory-cd8-t-cells-possess-unique-transcriptional-epigenetic-and-functional-adaptations-to-different-tissue-environments -
Clin Immunol. 2020
S. Jagle, M. Heeg, S. Grun, A. Rensing-Ehl, M. E. Maccari, C. Klemann, N. Jones, K. Lehmberg, C. Bettoni, K. Warnatz, B. Grimbacher, A. Biebl, U. Schauer, R. Hague, O. Neth, A. Mauracher, J. Pachlopnik Schmid, A. Fabre, L. Kostyuchenko, M. Fuhrer, M. R. Lorenz, K. Schwarz, J. Rohr, and S. Ehl.
2020/distinct-molecular-response-patterns-of-activating-stat3-mutations-associate-with-penetrance-of-lymphoproliferation-and-autoimmunity -
J Immunol. 2020
N. Diaz, M. Juarez, C. Cancrini, M. Heeg, P. Soler-Palacin, A. Payne, G. I. Johnston, E. Helmer, D. Cain, J. Mann, D. Yuill, F. Conti, S. Di Cesare, S. Ehl, M. Garcia-Prat, M. E. Maccari, A. Martin-Nalda, M. Martinez-Gallo, D. Moshous, V. Santilli, M. Semeraro, A. Simonetti, F. Suarez, M. Cavazzana, and S. Kracker.
2020/seletalisib-for-activated-pi3kdelta-syndromes_-open-label-phase-1b-and-extension-studies -
J Clin Immunol. 2020
A. Blincoe, M. Heeg, P. K. Campbell, M. Hines, A. Khojah, M. Klein-Gitelman, J. A. Talano, C. Speckmann, F. Touzot, A. Lankester, G. E. Legger, J. G. Riviere, M. Garcia-Prat, L. Alonso, M. C. Putti, K. Lehmberg, S. Maier, Y. El Chazli, M. A. Elmaksoud, I. Astigarraga, N. Kurjane, I. Bulina, V. Kenina, Y. Bryceson, J. Rascon, A. Lortie, G. Goldstein, C. Booth, A. Worth, E. Wassmer, E. G. Schmitt, J. T. Warren, J. J. Bednarski, S. Ali, K. Y. Chiang, J. Krueger, M. M. Henry, S. M. Holland, R. A. Marsh, S. Ehl, and E. Haddad.
2020/neuroinflammatory-disease-as-an-isolated-manifestation-of-hemophagocytic-lymphohistiocytosis -
Pediatr Blood Cancer. 2018
M. Heeg, S. Ammann, C. Klemann, M. Panning, V. Falcone, H. Hengel, K. Lehmberg, U. Zur Stadt, K. Wustrau, G. Janka, and S. Ehl.
2018/is-an-infectious-trigger-always-required-for-primary-hemophagocytic-lymphohistiocytosis_-lessons-from-in-utero-and-neonatal-disease -
J Virol. 2015
A. Hoh, M. Heeg, Y. Ni, A. Schuch, B. Binder, N. Hennecke, H. E. Blum, M. Nassal, U. Protzer, M. Hofmann, S. Urban, and R. Thimme.
2015/hepatitis-b-virus-infected-hepg2hntcp-cells-serve-as-a-novel-immunological-tool-to-analyze-the-antiviral-efficacy-of-cd8-t-cells-in-vitro -
Hepatology. 2012
M. Heeg, and R. Thimme.
2012/natural-killer-cells-and-hepatitis-c_-natural-killer-p46-expression-linked-to-antiviral-and-antifibrotic-activity